Statistical analysis of clinical data and immunohistochemical (IHC) staining showed the relocalization of membranous FGFRL1 in nonmalignant prostate to cytoplasmic and nuclear sites in PCa. Here, FGFRL1 is linked to posterior cortical atrophy.